Low prevalence of human papillomavirus (HPV) in Chinese patients with breast cancer

Journal of International Medical Research

Volumn 39, Issue 5, 2011, Pages 1636-1644

  Mou, X ^a,b,c   Chen, L ^a   Liu, F ^a   Shen, Y ^a   Wang, H ^a   Li, Y ^a   Yuan, L ^a   Lin, J ^a,a   Teng, Lisong ^a   Xiang, Charlie ^a,c,d  

^a ZHEJIANG UNIVERSITY   (China)

^b Institute of Molecular Pathology and Molecular Cell Biology   (China)

^c Zhejiang California International NanoSystems Institute   (China)

^d J Craig Venter Institute   (United States)

Author keywords

Breast Cancer; Human Papillomavirus; Polymerase Chain Reaction

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PYROSEQUENCING; RETROSPECTIVE STUDY; RISK FACTOR; VIRUS DETECTION;

EID: 80155172981     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900506     Document Type: Article

References (35)

1. Dumitrescu RG, Cotarla I: Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med 2005; 9: 208-221.
2. McPherson K, Steel CM, Dixon JM: ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000; 321: 624-628.
3. Dickson C: Role of the int-genes in murine mammary tumor development and implications for human breast cancer. Int J Cancer Suppl 1990; 5: 51-54.
4. Glaser SL, Hsu JL, Gulley ML: Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 2004; 13: 688-697.
5. Li N, Bi X, Zhang Y, et al: Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat 2010; 126: 515-520.
6. Faridi R, Zahra A, Khan K, et al: Oncogenic potential of human papillomavirus (HPV) and its relation with cervical cancer. Virol J 2011; 8: 269-276.
7. Mork J, Lie AK, Glattre E, et al: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131.
8. Liu F, Mou X, Zhao N, et al: Prevalence of human papillomavirus (HPV) in Chinese patients with colorectal cancer. Colorectal Dis 2010; 13: 865-871.
9. Koulos J, Symmans F, Chumas J, et al: Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol 1991; 4: 58-61.
10. Band V, Zajchowski D, Kulesa V, et al: Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A 1990; 87: 463-467.
11. Wazer DE, Liu XL, Chu Q, et al: Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A 1995; 92: 3687-3691.
12. Di Lonardo A, Venuti A, Marcante ML: Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992; 21: 95-100.
13. Wrede D, Luqmani YA, Coombes RC, et al: Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 1992; 65: 891-894.
14. Czerwenka K, Heuss F, Hosmann JW, et al: Human papilloma virus DNA: a factor in the pathogenesis of mammary Paget's disease? Breast Cancer Res Treat 1996; 41: 51-57.
15. Gopalkrishna V, Singh UR, Sodhani P, et al: Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 1996; 39: 197-202.
16. Hennig EM, Suo Z, Thoresen S, et al: Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat 1999; 53: 121-135.
17. Yu Y, Morimoto T, Sasa M, et al: HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res 1999; 19: 5057-5061.
18. Liu Y, Klimberg VS, Andrews NR, et al: Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 2001; 4: 329-334.
19. Damin AP, Karam R, Zettler CG, et al: Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 2004; 84: 131-137.
20. Kan CY, Lacopetta BJ, Lawson JS, et al: Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 2005; 93: 946-948.
21. Kroupis C, Markou A, Vourlidis N, et al: Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006; 39: 727-731.
22. Lindel K, Forster A, Altermatt HJ, et al: Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 2007; 16: 172-177.
23. Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ, et al: Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 2009; 114: 189-194.
24. de Villiers EM, Sandstrom RE, zur Hausen H, et al: Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005; 7: R1-R11.
25. Li T, Lu ZM, Guo M, et al: p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 2002; 95: 2571-2576.
26. Widschwendter A, Brunhuber T, Wiedemair A, et al: Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 2004; 31: 292-297.
27. Bratthauer GL, Tavassoli FA, O'Leary TJ: Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract 1992; 188: 384-386.
28. Tsai JH, Tsai CH, Cheng MH, et al: Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005 75: 276-281.
29. Fuessel Haws AL, He Q, Rady PL, et al: Nested PCR with the PGMY09/11 and GP5+/6+ primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 2004; 122: 87-93.
30. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al: GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-787.
31. Gharizadeh B, Kalantari M, Garcia CA, et al: Typing of human papillomavirus by pyrosequencing. Lab Invest 2001; 81: 673-679.
32. Khan NA, Castillo A, Koriyama C, et al: Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 2008; 99: 408-414.
33. de Cremoux P, Thioux M, Lebigot I, et al: No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008; 109: 55-58.
34. Yu Y, Morimoto T, Sasa M, et al: Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer 2000; 7: 33-36.
35. Akil N, Yasmeen A, Kassab A, et al: High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer 2008; 99: 404-407.